Indicators
Indicators
Value
Direction
MACD(12,26,9)
-0.003
Sell
RSI(14)
40.709
Neutral
STOCH(KDJ)(9,3,3)
47.590
Neutral
ATR(14)
0.130
High Vlolatility
CCI(14)
-196.548
Sell
Williams %R
60.538
Sell
TRIX(12,20)
-0.474
Sell
StochRSI(14)
0.000
Oversold
IM Cannabis Corp
IMCC1.280USD
-0.020-1.54%
Close 02/02, 16:00（ET）Quotes delayed by 15 min
6.72MMarket Cap
LossP/E TTM
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score of IM Cannabis Corp
Currency: USD Updated: 2026-02-02Key Insights
IM Cannabis Corp's fundamentals are relatively stable, and its growth potential is high.Its valuation is considered fairly valued, ranking 28 out of 30 in the Food & Drug Retailing industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as , with the highest price target at 0.00.Despite a weak stock market performance over the past month, the company shows strong fundamentals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
IM Cannabis Corp's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Neutral
IM Cannabis Corp Highlights
StrengthsRisks
IM Cannabis Corp. is an international cannabis company that provides cannabis products to medical patients in Israel and Germany. The Company's ecosystem operates in Israel through its subsidiaries, which import and distribute cannabis to medical patients, leveraging years of proprietary data and patient insights. The Company also operates medical cannabis retail pharmacies, online platforms, distribution centers, and logistical hubs in Israel that enable the safe delivery and quality control of its products throughout the entire value chain. In Germany, the Company’s ecosystem operates through Adjupharm GmbH, where it distributes cannabis to pharmacies for medical cannabis patients. The Company's brands include The Craft Collection, The Top-Shelf Collection, The Signature Collection, The Full Spectrum Extracts, Roma, The WAGNERS, BLKMKT, LOT420, The PICO collection, and Flower.
Growing
The company is in a growing phase, with the latest annual income totaling USD 37.56M.
Undervalued
The company’s latest PE is -1.48, at a low 3-year percentile range.
Institutional Buying
The latest institutional holdings are 964.07K shares, increasing 38.56% quarter-over-quarter.
Held by James Simons
Star Investor James Simons holds 11.43K shares of this stock.
Analyst Rating
Based on
0
analysts
--
Current Rating
0.000
Target Price
0.00%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Financial Health
Currency: USD Updated: 2026-02-02The current financial score of IM Cannabis Corp is 6.29, ranking 24 out of 30 in the Food & Drug Retailing industry. Its financial status is weak, and its operating efficiency is average. Its latest quarterly revenue reached 9.87M, representing a year-over-year decrease of 0.05%, while its net profit experienced a year-over-year decrease of 296.69%.
Score
Financials
4.11
Key Metrics
Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
Relevant data have not been disclosed by the company yet.
Quality of Earnings
6.89
Operational Efficiency
6.39
Growth Potential
6.98
Shareholder Returns
7.07
IM Cannabis Corp's Company Valuation
Currency: USD Updated: 2026-02-02The current valuation score of IM Cannabis Corp is 8.08, ranking 12 out of 30 in the Food & Drug Retailing industry. Its current P/E ratio is -1.48, which is -97.71% below the recent high of -0.03 and -408.21% above the recent low of -7.54.
Score
Valuation Dimensions
P/E
P/B
P/S
P/CF
Industry Ranking 28/30
Relevant data have not been disclosed by the company yet.
Earnings Forecast
Currency: USD Updated: 2026-02-02No earnings forecast score is currently available for IM Cannabis Corp. The Food & Drug Retailing industry's average is 7.64.
Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
No Data
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Relevant data have not been disclosed by the company yet.
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Price Momentum
Currency: USD Updated: 2026-02-02The current price momentum score of IM Cannabis Corp is 4.96, ranking 27 out of 30 in the Food & Drug Retailing industry. Currently, the stock price is trading between the resistance level at 1.51 and the support level at 1.10, making it suitable for range-bound swing trading.
Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Indicators
The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.
This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.
Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.
Moving Average
Indicators
Value
Direction
MA5
1.348
Sell
MA10
1.351
Sell
MA20
1.381
Sell
MA50
1.504
Sell
MA100
1.615
Sell
MA200
2.033
Sell
Institutional Confidence
Currency: USD Updated: 2026-02-02The current institutional shareholding score of IM Cannabis Corp is 3.00, ranking 16 out of 30 in the Food & Drug Retailing industry. The latest institutional shareholding proportion is 18.37%, representing a quarter-over-quarter increase of 301.14%. The largest institutional shareholder is James Simons, holding a total of 11.43K shares, representing 0.22% of shares outstanding, with 1.00% increase in holdings.
Score
Institutional Shareholding
Relevant data have not been disclosed by the company yet.
Risk Assessment
Currency: USD Updated: 2026-02-02The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Food & Drug Retailing domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of IM Cannabis Corp is 1.41, ranking 27 out of 30 in the Food & Drug Retailing industry. The company's beta value is 2.01. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets.
Score
Beta vs S&P 500 index
2.01
VaR
+9.53%
240-Day Maximum Drawdown
+83.90%
240-Day Volatility
+160.48%
Return
Best Daily Return
60 days
+34.20%
120 days
+34.20%
5 years
+84.12%
Worst Daily Return
60 days
-19.48%
120 days
-19.48%
5 years
-43.87%
Sharpe Ratio
60 days
+0.27
120 days
-0.85
5 years
-0.36
Risk Assessment
Maximum Drawdown
240 days
+83.90%
3 years
+87.00%
5 years
+99.75%
Return-to-Drawdown Ratio
240 days
-0.50
3 years
-0.26
5 years
-0.20
Skewness
240 days
+3.27
3 years
+2.90
5 years
+2.65
Volatility
Realised Volatility
240 days
+160.48%
5 years
+147.49%
Standardised True Range
240 days
+20.64%
5 years
+371.86%
Downside Risk-Adjusted Return
120 days
-141.83%
240 days
-141.83%
Maximum Daily Upside Volatility
60 days
+104.45%
Maximum Daily Downside Volatility
60 days
+92.50%
Liquidity
Average Turnover Rate
60 days
+2.77%
120 days
+5.31%
5 years
--
Turnover Deviation
20 days
-89.93%
60 days
-79.92%
120 days
-61.43%
Peer Comparison
Food & Drug Retailing
IM Cannabis Corp
IMCC
4.22 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Guardian Pharmacy Services Inc
GRDN
8.40 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Bbb Foods Inc
TBBB
8.33 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Performance Food Group Co
PFGC
8.11 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Walmart Inc
WMT
8.10 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Kroger Co
KR
7.93 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
